Curriculum Vitae s229

CURRICULUM VITAE ELIAS ERIKSSON Born: August 7, 1956, Göteborg, Sweden

Doctoral degree 1985 Ph D (Med Dr), Department of Pharmacology, Göteborg University. Research area: pharmacology, title: "Experimental Psychoneuroendocrinology: Brain alpha-2-adrenoceptors and growth hormone release".

Qualification as Associate Professor 1988 Department of Pharmacology, Göteborg University

Current and previous positions 2001- Professor, Department of Pharmacology, Göteborg University, 80 % research in position 2000- Researcher, Swedish Research Council 1996-2001 Associated professor, Department of Pharmacology, Göteborg University

People awarded doctorates (main supervisor) 1983-1988 Maria Carlsson "Sex differences in monoaminergic mechanisms in rat". 1988-1996 Agneta Ekman "On dopamine D2 and D3 receptor pharmacology". 1988-1996 Charlotta Sundblad "Serotonin, androgens and behaviour: On the pathophysiology and treatment of the premenstrual syndrome". 1990-1999 Christer Nilsson "In vitro studies of dopamine D2 and D3 receptor pharmacology: full, partial, and inverse agonism". 1997-2002 Marie Olsson "On the possible role of serotonin and angiotensin for the respiratory abnormalities observed in panic disorder and premenstrual dysphoria”. 1998-2003 Jonas Melke “Importance of serotonin-related candidate genes for human behaviour”. 1998-2003 Hoi Por Ho “On the biology of premenstrual dysphoria and panic disorder”. 1998-2003 Lars Westberg “Polymorphisms in sex steroid-related genes: Effects on hormone levels and behaviour”. 1996-2004 Monika Hellstrand “Dopamine D2 and D3 receptors. Studies on transduction mechanisms and on the role of a D3 gene polymorphism”. 2002- Kristina Annerbrink >50%. 2002- Jessica Bah: >50% 2003- Susanne Henningsson: >50% 2005- Olle Bergman: <50%.

Postdoctoral researchers 1. Jonas Melke (2006-), 2. Lars Westberg (2006-)

National and international assignments The chairman of Swedish Society for Biological Psychiatry and Swedish Serotonin Society. Founding member of the Swedish Schizophrenia Foundation, and a member of its board until 2004. Member of the board of Scandinavian College of Neuropsychopharmacology (1993 to 1999). Member of the editorial board of Journal of Neural Transmission from 1997 to 2000. Member of the editorial board of Archives of Women's Mental Health. Was the member of an expert panel addressing the Food and Drug Administration (FDA) (arranged by Columbia University, NY, and Eli Lilly Company) regarding premenstrual dysphoria. Was a member of the SBU (=The Swedish Council on Technology Assessment in Health Care) expert committee on the treatment of anxiety disorders. Was the author of treatment recommendations for the Swedish Board of Health and Welfare regarding Parkinson's disease. Was the member of an expert panel of the Swedish Medical Product Agency regarding anxiety disorders and of another one regarding depression. Was a member of an expert panel of the Swedish Board of Health and Welfare regarding attention deficit disorder. Was a member of a international task group for the World Psychiatric Association regarding premenstrual dysphoria. Was a member of expert panels/advisory boards for several international pharmaceutical companies: Eli Lilly (USA), Ciba-Geigy (Switzerland), Pfizer (USA), SmithKline Beecham (England), Organon (The Netherlands), Lundbeck (Denmark), Glaxo SmithKline (UK), Rhone-Poulenc Rorer (France) and Schering (Germany). Scientific collaboration with Ciba-Geigy, Bristol-Myers Squibb, Novo Nordisk, Glaxo SmithKline, Merck, and Lundbeck.

Communication of research results Invited speaker/chairman at 59 scientific international, extra-Scandinavian meetings. Invited speaker at numerous national and Scandinavian meetings (>130). Organized, together with Arvid Carlsson and Carol Tamminga, an international workshop on schizophrenia in Göteborg 1994. Co-editor (together with Steiner and Yonkers) for a book on “Mood Disorders in Women” (Dunitz, London), that was described in a review in New England Journal of Medicine as “a scholastic triumph” that “sets a new benchmark for achievement in this field” and “would function as a good model for any textbook on mood disorders”. Has written more than 30 review papers. Has contributed with two chapters in a Swedish book on ADHD. Founder and co-owner of a small research company. Has participated actively in the public debate on issues such as funding of research and ethics in clinical research.

Other Qualifications Has served as faculty opponent at 5 dissertations in Sweden and Norway. Won the award for best teacher at Sahlgrenska Akademin in 2000.

Funding (2007) Swedish Science Council: 800.000 SEK / year (project). LUA/ALF: 1.800.000 SEK / year. H Lundbeck: 2.700.000 SEK (awarded in 2007). Bristol Myers Squibbb: 450.000 SEK (awarded ion 2006). Söderberg’s Foundation: 1.000.000 SEK (awarded in 2007). KK Foundation: 300.000 SEK / year. Vinnova: 400.000 SEK / year. Grants for equipment past 5 years (Lundberg foundation): Appr 5.000.000 SEK. Co-applicant of a grant from Riksbanken Jubileumsfond (PI: Paul Lichtenstein) that was approved in 2004: 1.200.000 SEK.